Rapid effects of zoledronic acid in reducing bone complications in patients with bone metastases in the first 3 months of treatment

被引：0
|
作者：
Saad, F.
Chen, Y. M.
机构：
[1] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada
[2] Novartis Oncol, E Hanover, NJ USA
来源：
CANCER TREATMENT REVIEWS | 2006年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
131
引用
收藏
页码：S51 / S52
页数：2
相关论文
共 50 条
  • [31] Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid
    Lipton, A
    Colombo-Berra, A
    Bukowski, RM
    Rosen, L
    Zheng, M
    Urbanowitz, G
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6397S - 6403S
  • [32] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases.
    Lipton, A.
    Chen, Y. M.
    Milton, S.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S62 - S62
  • [33] Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series
    Montella, Liliana
    Addeo, Raffaele
    Palmieri, Giovannella
    Caraglia, Michele
    Cennamo, Gregorio
    Vincenzi, Bruno
    Guarrasi, Rosario
    Mamone, Rosanna
    Faiola, Vincenzo
    Frega, Nicola
    Capasso, Elena
    Maiorino, Luigi
    Leopardo, Davide
    Pizza, Carmine
    Montesarchio, Vincenzo
    Del Prete, Salvatore
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (06) : 1137 - 1143
  • [34] Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma
    Orita, Yorihisa
    Sugitani, Iwao
    Toda, Kazuhisa
    Manabe, Jun
    Fujimoto, Yoshihide
    THYROID, 2011, 21 (01) : 31 - 35
  • [35] Treatment of Bone Metastases in Lung Cancer: The Actual Role of Zoledronic Acid
    Ricciardi, Serena
    de Marinis, Filippo
    REVIEWS ON RECENT CLINICAL TRIALS, 2009, 4 (03) : 205 - 211
  • [36] Future directions for zoledronic acid and new agents for the treatment of bone metastases
    Hei, YJ
    EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (05) : 55 - 62
  • [37] Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series
    Liliana Montella
    Raffaele Addeo
    Giovannella Palmieri
    Michele Caraglia
    Gregorio Cennamo
    Bruno Vincenzi
    Rosario Guarrasi
    Rosanna Mamone
    Vincenzo Faiola
    Nicola Frega
    Elena Capasso
    Luigi Maiorino
    Davide Leopardo
    Carmine Pizza
    Vincenzo Montesarchio
    Salvatore Del Prete
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1137 - 1143
  • [38] Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases
    Li, Fenqiang
    Wang, Wenhui
    Li, Li
    Su, Dongjun
    Chang, Yaowen
    Guo, Gang
    He, Xuewen
    Li, Baohua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (02) : 539 - 544
  • [39] Bone Turnover Markers as Predictors of Mortality Risk in Prostate Cancer Patients with Bone Metastases Following Treatment with Zoledronic Acid
    Jung, Klaus
    Miller, Kurt
    Wirth, Manfred
    Albrecht, Michael
    Lein, Michael
    EUROPEAN UROLOGY, 2011, 59 (04) : 604 - 612
  • [40] Survival in breast cancer patients with bone metastases and reductions in markers of bone resorption during zoledronic acid treatment.
    Lipton A
    Cook R
    Major P
    Smith M
    Coleman R
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S39 - S39
12345